George Sellers
Stock Analyst at Stephens & Co.
(1.08)
# 3,867
Out of 5,150 analysts
45
Total ratings
28.57%
Success rate
-6.56%
Average return
Main Sectors:
Stocks Rated by George Sellers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ESTA Establishment Labs Holdings | Maintains: Overweight | $85 → $90 | $71.14 | +26.51% | 8 | Feb 25, 2026 | |
| GKOS Glaukos | Maintains: Overweight | $115 → $145 | $115.37 | +25.68% | 5 | Jan 2, 2026 | |
| TFX Teleflex | Maintains: Overweight | $275 → $290 | $119.18 | +143.33% | 9 | Aug 2, 2024 | |
| VCEL Vericel | Maintains: Overweight | $56 → $58 | $34.96 | +65.90% | 2 | Aug 2, 2024 | |
| TMDX TransMedics Group | Maintains: Overweight | $151 → $178 | $147.66 | +20.55% | 2 | Aug 2, 2024 | |
| ANIK Anika Therapeutics | Reiterates: Equal-Weight | $24 | $14.36 | +67.13% | 6 | May 29, 2024 | |
| ENOV Enovis | Initiates: Overweight | $72 | $25.79 | +179.18% | 1 | Feb 13, 2024 | |
| APYX Apyx Medical | Maintains: Overweight | $8 → $5 | $3.30 | +51.52% | 2 | Nov 10, 2023 | |
| TMCI Treace Medical Concepts | Reiterates: Equal-Weight | $25 | $1.47 | +1,600.68% | 4 | Sep 12, 2023 | |
| STAA STAAR Surgical Company | Reiterates: Overweight | $57 | $19.22 | +196.57% | 6 | Aug 14, 2023 |
Establishment Labs Holdings
Feb 25, 2026
Maintains: Overweight
Price Target: $85 → $90
Current: $71.14
Upside: +26.51%
Glaukos
Jan 2, 2026
Maintains: Overweight
Price Target: $115 → $145
Current: $115.37
Upside: +25.68%
Teleflex
Aug 2, 2024
Maintains: Overweight
Price Target: $275 → $290
Current: $119.18
Upside: +143.33%
Vericel
Aug 2, 2024
Maintains: Overweight
Price Target: $56 → $58
Current: $34.96
Upside: +65.90%
TransMedics Group
Aug 2, 2024
Maintains: Overweight
Price Target: $151 → $178
Current: $147.66
Upside: +20.55%
Anika Therapeutics
May 29, 2024
Reiterates: Equal-Weight
Price Target: $24
Current: $14.36
Upside: +67.13%
Enovis
Feb 13, 2024
Initiates: Overweight
Price Target: $72
Current: $25.79
Upside: +179.18%
Apyx Medical
Nov 10, 2023
Maintains: Overweight
Price Target: $8 → $5
Current: $3.30
Upside: +51.52%
Treace Medical Concepts
Sep 12, 2023
Reiterates: Equal-Weight
Price Target: $25
Current: $1.47
Upside: +1,600.68%
STAAR Surgical Company
Aug 14, 2023
Reiterates: Overweight
Price Target: $57
Current: $19.22
Upside: +196.57%